186 related articles for article (PubMed ID: 32234046)
21. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA
Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
[TBL] [Abstract][Full Text] [Related]
22. Analysis of inappropriate medication use and drug interactions in older people in South Korea
.
Kim H; Kim HS; Ko H; Choi J; Cho NH
Int J Clin Pharmacol Ther; 2017 Nov; 55(11):847-852. PubMed ID: 28853697
[TBL] [Abstract][Full Text] [Related]
23. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Marzolini C; Elzi L; Gibbons S; Weber R; Fux C; Furrer H; Chave JP; Cavassini M; Bernasconi E; Calmy A; Vernazza P; Khoo S; Ledergerber B; Back D; Battegay M;
Antivir Ther; 2010; 15(3):413-23. PubMed ID: 20516560
[TBL] [Abstract][Full Text] [Related]
25. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
26. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
[No Abstract] [Full Text] [Related]
27. Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
Deutschmann E; Bucher HC; Jaeckel S; Gibbons S; McAllister K; Scherrer AU; Braun DL; Cavassini M; Hachfeld A; Calmy A; Battegay M; Cipriani M; Elzi L; Young J; Lopez-Centeno B; Berenguer J; Khoo S; Moffa G; Marzolini C;
Clin Infect Dis; 2021 Oct; 73(7):e2145-e2152. PubMed ID: 32634832
[TBL] [Abstract][Full Text] [Related]
28. Potential drug-drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan.
Kunimoto Y; Matamura R; Ikeda H; Fujii S; Kimyo T; Kitagawa M; Nakata H; Kobune M; Miyamoto A; Fukudo M
J Pharm Health Care Sci; 2021 Dec; 7(1):43. PubMed ID: 34847955
[TBL] [Abstract][Full Text] [Related]
29. Review of prescription medications in home-based older adults with stroke: a pilot study.
Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N
Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
[TBL] [Abstract][Full Text] [Related]
30. Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey.
Grizzle AJ; Horn J; Collins C; Schneider J; Malone DC; Stottlemyer B; Boyce RD
J Med Internet Res; 2019 Jan; 21(1):e11182. PubMed ID: 30609981
[TBL] [Abstract][Full Text] [Related]
31. Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) - Sex differences and associations with morbidity and medication use.
Toepfer S; Bolbrinker J; König M; Steinhagen-Thiessen E; Kreutz R; Demuth I
PLoS One; 2019; 14(12):e0226511. PubMed ID: 31887163
[TBL] [Abstract][Full Text] [Related]
32. Frequency and determinants of potential drug-drug interactions in an elderly population receiving regular home visits by GPs--results of the home medication review in the AGnES-studies.
Hoffmann W; van den Berg N; Thyrian JR; Fiss T
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1311-8. PubMed ID: 21919114
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations.
Bakker T; Dongelmans DA; Nabovati E; Eslami S; de Keizer NF; Abu-Hanna A; Klopotowska JE
J Clin Pharmacol; 2022 Jun; 62(6):706-720. PubMed ID: 34957573
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?
Domínguez-Alonso JA; Conde-Estévez D; Bosch D; Pi-Figueras M; Tusquets I
Clin Transl Oncol; 2021 Jan; 23(1):65-73. PubMed ID: 32449126
[TBL] [Abstract][Full Text] [Related]
35. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
[TBL] [Abstract][Full Text] [Related]
36. Polypharmacy, potentially inappropriate medication and pharmacogenomics drug exposure in the Rhineland Study.
de Vries FM; Stingl JC; Breteler MMB
Br J Clin Pharmacol; 2021 Jul; 87(7):2732-2756. PubMed ID: 33232531
[TBL] [Abstract][Full Text] [Related]
37. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
Noor S; Ismail M; Khan F
Front Pharmacol; 2019; 10():1032. PubMed ID: 31607905
[No Abstract] [Full Text] [Related]
38. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
[TBL] [Abstract][Full Text] [Related]
39. Drug utilization, prescription errors and potential drug-drug interactions: an experience in rural Sri Lanka.
Rathish D; Bahini S; Sivakumar T; Thiranagama T; Abarajithan T; Wijerathne B; Jayasumana C; Siribaddana S
BMC Pharmacol Toxicol; 2016 Jun; 17(1):27. PubMed ID: 27342193
[TBL] [Abstract][Full Text] [Related]
40. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
Bauer A; Klemm M; Rizas KD; Hamm W; von Stülpnagel L; Dommasch M; Steger A; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri H; Malik M; Schmidt G; Zabel M;
Lancet; 2019 Oct; 394(10206):1344-1351. PubMed ID: 31488371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
